Perfil
Priti Patel is a professional who has worked in the medical industry.
She has held positions such as Medical Director at Onyx Pharmaceuticals, Senior & Executive Medical Director at Acerta Pharma LLC, and VP & Head-Hematology Clinical Development at AstraZeneca, Inc. Currently, she is the Chief Medical Officer at Neoleukin Therapeutics, Inc. Dr. Patel has an undergraduate degree from The Johns Hopkins University and a doctorate from the University of Vermont College of Medicine.
Antiguos cargos conocidos de Priti Patel.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUROGENE INC. | Director Técnico/Científico/I+D | 31/03/2023 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director Técnico/Científico/I+D | - |
| Acerta Pharma LLC | Director Técnico/Científico/I+D | - |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
Formación de Priti Patel.
| The Johns Hopkins University | Undergraduate Degree |
| University of Vermont College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
| Acerta Pharma LLC | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Priti Patel
